| Dr Henry Michael Webb, MD | |
|
601 S 8th St, Griffin, GA 30224-4213 | |
| (770) 228-2721 | |
| Not Available |
| Full Name | Dr Henry Michael Webb |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 601 S 8th St, Griffin, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841233277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 020620 (Georgia) | Primary |
| Entity Name | Nauc Twoandhalf |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396038774 PECOS PAC ID: 3072781145 Enrollment ID: O20110714000744 |
News Archive
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
People who purchase health insurance on their own were faced with premium increases averaging 20 percent when they last sought to renew their coverage, according to a survey released Monday by the Kaiser Family Foundation.
The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.
A multicenter study led by Christian Haass and Michael Ewers of Ludwig-Maximilians-Universitaet in Munich has identified a biomarker associated with the activation of an innate immune response to neural damage during early stages of Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Georgia Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952746638 PECOS PAC ID: 4082853262 Enrollment ID: O20130619000316 |
News Archive
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
People who purchase health insurance on their own were faced with premium increases averaging 20 percent when they last sought to renew their coverage, according to a survey released Monday by the Kaiser Family Foundation.
The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.
A multicenter study led by Christian Haass and Michael Ewers of Ludwig-Maximilians-Universitaet in Munich has identified a biomarker associated with the activation of an innate immune response to neural damage during early stages of Alzheimer's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Henry Michael Webb, MD 14050 Nw 14th St, Suite 190, Sunrise, FL 33323-2865 Ph: (800) 424-3672 | Dr Henry Michael Webb, MD 601 S 8th St, Griffin, GA 30224-4213 Ph: (770) 228-2721 |
News Archive
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
People who purchase health insurance on their own were faced with premium increases averaging 20 percent when they last sought to renew their coverage, according to a survey released Monday by the Kaiser Family Foundation.
The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.
A multicenter study led by Christian Haass and Michael Ewers of Ludwig-Maximilians-Universitaet in Munich has identified a biomarker associated with the activation of an innate immune response to neural damage during early stages of Alzheimer's disease.
› Verified 4 days ago
Dr. Jestina S Mason, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Dr. Dwayne L Watkins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 S 9th St, Griffin, GA 30224 Phone: 770-233-9293 Fax: 770-233-0998 | |
Dr. Ike A Nwaobi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 704-676-3147 | |
Dr. Kamlesh Patel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Nneka Clara Azih, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Dr. Jehangir Tanveer Pirzada, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 248-709-6524 |